Extracorporeal Membrane Oxygenation Market Size By Modality (Venoarterial, Veno-venous, Arteriov0enous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Aug 2019  |  Report ID: GMI2720  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 141   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Extracorporeal Membrane Oxygenation Market size valued over USD 285 million in 2018 and is estimated to witness more than 3.5% CAGR from 2019 to 2025.
 

Germany extracorporeal membrane oxygenation market size, by application, 2018 & 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Rise in number of ECMO centers coupled with growing awareness about extracorporeal membrane oxygenation systems will drive the ECMO systems market over the projected timeframe. Increase in prevalence of respiratory conditions including respiratory distress syndrome (difficulty breathing) has escalated the adoption rate of ECMO machines.  
 

Growing use of ECMO in adults for treating various conditions related to heart and lungs will drive the ECMO procedure volume, thereby stimulating the market growth. Increasing number of adults suffering from pneumonia, cardiac failure, trauma and other severe conditions will positively impact the business growth.
 

Technological advancements including the polymethylpentene (PMP) fibre technology has expanded the development of artificial membrane having low resistance and improved biocompatibility to be used for extended duration. Such technological advancements in the systems has reduced the mortality rate as well as augmented the device adoption rate. However, risks such as bleeding, infection and device failure associated with the use of ECMO system will hamper the industry expansion to certain extent over the analysis period.
 

Extracorporeal Membrane Oxygenation Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 285 Million (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 3.5% 2025 Value Projection: 370 Million (USD)
Pages: 141 Tables, Charts & Figures: 98
Geographies covered (18): U.S., Canada, Germany, UK, Italy, France, Spain, China, India, Japan, Taiwan, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa, Kuwait
Segments covered: Modality, Application, Patient Population and Region
Companies covered (14): Abbott Laboratories, Alung Technologies, Braile Biomedical, Edwards Lifesciences Corp, Elsius Biomedical Inc., Eurosets Srl, Getinge Group, LivaNova PLC, Medtronic Inc., MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Spectrum Medical, Terumo Corporation
Growth Drivers:
  • Increase in cases of cardiopulmonary diseases and respiratory failure in Asia Pacific
  • Technological advancements in ECMO device in North America
  • Rising patient awareness about benefits delivered by extracorporeal membrane oxygenation device in Latin America
  • Rising government initiatives and programs in Europe
Pitfalls & Challenges:
  • High costs of equipment
  • Dearth of skilled professionals
  • Risks related to ECMO device

Get more details on this report - Request Free Sample PDF
 

Extracorporeal Membrane Oxygenation Market, By Modality

Veno-venous ECMO market is anticipated to grow considerably during the forecast period to reach USD 136.5 million by 2025. Availability of cannulas such as Avalon ELITE and Protek Duo in the market that use the internal jugular approach during ECMO procedure will drive the device adoption rate over the coming years. The benefits associated with these devices include reduced risk of bleeding, ease of mobilization and lower rate of recirculation driving the Veno-venous extracorporeal membrane oxygenation market. Additionally, increasing incidence of severe acute respiratory failure will further drive the business growth.
 

Veno-arterial (VA) ECMO segment is projected to be the fastest growing segment accounting for over 45% market share in 2018. Increasing incidence of cardiac disorders will act as major impact rendering factor for the growth of veno-arterial ECMO market. VA-ECMO offers enhanced hemodynamic support to patients suffering from severe conditions including cardiogenic shock. It is also used in providing periprocedural support to the acute heart failure patients. Thus, growing application of veno-arterial (VA) ECMO in treating cardiovascular conditions will stimulate the business growth over the projected timeframe.
 

Extracorporeal Membrane Oxygenation Market, By Application

Extracorporeal cardiopulmonary resuscitation (ECPR) market is estimated to witness more than 4% CAGR during the forecast period. Increasing number of people suffering from chronic diseases such as obesity and diabetes, highly susceptible to suffer from cardiovascular conditions will drive the extracorporeal cardiopulmonary resuscitation (ECPR) market. ECPR is majorly used in patients suffering from cardiac arrest. Thus, rising incidence of cardiac arrest will drive the industry growth.  
 

Cardiac application of extracorporeal membrane oxygenation system will grow lucratively over the forecast period to reach USD 124.2 million by 2025. ECMO is used to provide support to patients recovering from cardiac arrest or during procedures in cardiac catherization laboratories. It also acts as a bridge to cardiac assist devices including the left ventricular assist device (LVAD). Thus, the growing application of ECMO in treating cardiac patients will drive the industry growth significantly over the foreseeable period.
 

Extracorporeal Membrane Oxygenation Market, By Patient Population

Brazil extracorporeal membrane oxygenation market share, by patient population, 2018

Get more details on this report - Request Free Sample PDF
 

Paediatric patient population subjected to ECMO held over 20% market share of the global ECMO market in 2018. Rising number of children suffering from severe acute respiratory distress syndrome (ARDS) will act as primary driver for growing usage of ECMO in children. Thus, the growing acceptance of clinical utility and high success rate of veno-venous ECMO in treating paediatric patients suffering from severe ARDS will drive the segmental growth over the analysis period.
 

Extracorporeal Membrane Oxygenation Market, By Region

Asia Pacific extracorporeal membrane oxygenation market share, by country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Taiwan market held over 15% of Asia Pacific ECMO market in 2018. Large number of patients kept on ECMO coupled with high incidence of severe cardiorespiratory conditions requiring ECMO support will drive the market growth over the forecast timeline. Rising awareness about the ECMO device has surged its demand, thereby stimulating the market growth.

 

Presence of Service d'Aide Medical d'Urgence (SAMU) in France that implements ECMO in emergency cases (including on streets) to restore the body functions such as blood flow and limiting the occurrence of ischemic coronary arteries and brain, pre-hospitalization of the patient will positively impact the growth of France market to reach USD 18 million by 2025. Moreover, growing awareness about ECMO device along with rising prevalence of severe respiratory and cardiac diseases in the country will drive the France ECMO industry growth.
 

Competitive Market Share

Some of the notable industry players include Medtronic, Getinge, LivaNova, Terumo, Alung Technologies and Abbott. Merger and acquisitions, strategic collaboration and partnerships are major strategies followed by these companies. Advent of innovative products in the market has escalated the competition in the market resulting in significant investment towards research and development by the companies.  
 

Recent industry developments:

  • In May 2018, EOLIA trial results indicated that patients subjected to appropriate ventilation management strategy along with early ECMO showed reduced mortality rate among patients suffering from severe acute respiratory distress syndrome (ARDS). Maquet Cardiopulmonary GmbH provided devices required for the EOLIA trial.
     
  • In September 2017, CytoSorbents Corporation launched the CytoSorb Therapeutic ECMO kit in Austria. The kit combines CytoSorb blood purification cartridge with innovative tubing connector set that allows easy integration in most of the commercial ECMO systems available in the market.
     

Global Extracorporeal Membrane Oxygenation Industry Background

ECMO was initially perceived in 1940s for the treatment of neonates and for research purpose. Since 1974, over 17,000 infants have been treated with ECMO with 78% survival rate. Although there has been substantial development in ECMO fundamentals for 3 decades, technical elements continue to evolve to improve safety and enhance maneuverability. The introduction of less intrusive and smaller circuits in the equipment has improved portability, thus lowering several mechanical issues. Introduction of polymethyl pentene (PMP) fibre technology with low resistance and more biocompatibility has enhanced the development artificial membrane in ECMO with extended use. However, research continues towards accelerating the development of wearable and compact artificial lungs that are used for patient’s sustenance for prolonged period during the ECMO procedure. Thus, technological adoption, rapid use of ECMO and new centers adopting ECMO procedures will support the growth of extracorporeal membrane oxygenation Industry worldwide.

Frequently Asked Questions (FAQ) :

The market size of extracorporeal membrane oxygenation exceeded USD 285 million in 2018.
The industry share of extracorporeal membrane oxygenation is estimated to witness more than 3.5% CAGR from 2019 to 2025.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Aug 2019
  • Pages: 141
  • Tables: 90
  • Charts / Figures: 8
  • Companies covered: 14
  • Countries covered: 18

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X